Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.76 |
| ▸ | CPA1 | P15085 | 7/20 | 0.66 |
| ▸ | CPA3 | P15088 | 3/20 | 0.66 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.66 |
| ▸ | CPB1 | P15086 | 1/20 | 0.66 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.66 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.65 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.65 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.65 |
| ▸ | ANPEP | P15144 | 1/20 | 0.61 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.59 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5171909 | 1.00 | CYP1A2 (0.76) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL4738634 | 1.00 | CYP1A2 (0.76) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| Hydrochloric Acid SCHEMBL23699291 | 0.98 | CYP1A2 (0.73) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| Ethyl Chloride SCHEMBL1185929 | 0.91 | CYP1A2 (0.63) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL6532060 | 0.89 | CYP1A2 (0.60) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL4664822 | 0.87 | CYP1A2 (1.00) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL19532713 | 0.86 | CYP1A2 (0.61) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL6609906 | 0.86 | CYP1A2 (0.61) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL7353741 | 0.86 | CYP1A2 (0.61) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL7439697 | 0.85 | CYP1A2 (0.86) | CYP1A2CPA1CPA3FOLH1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 372 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112174842-B | Method for preparing (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-112209850-B | Method for preparing (S) -3-amino-2-benzyl methyl propionate | 苏州山青竹生物医药有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-213885030-U | Purification device of (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-213886139-U | Equipment for producing (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-213443914-U | Storage device of (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2021-06-15 | — | — | CN | claimed |
| CN-112209850-A | Method for preparing (S) -3-amino-2-benzyl methyl propionate | 苏州山青竹生物医药有限公司 | 2021-01-12 | — | — | CN | claimed |
| CN-112174842-A | Method for preparing (S) -3-amino-2-benzyl propionic acid | 苏州山青竹生物医药有限公司 | 2021-01-05 | — | — | CN | claimed |
| CN-107445740-A | A kind of landscape flower growth composite modified fertilizer of special efficient and preparation method thereof | 林愿 | 2017-12-08 | — | — | CN | claimed |
| CN-102083810-A | Activator of peroxisome proliferator activated receptor | NIPPON CHEMIPHAR CO | 2011-06-01 | — | — | CN | claimed |
| US-20090062521-A1 | AMIDITE FOR SYNTHESIZING MODIFIED NUCLEIC ACID AND METHOD FOR SYNTHESIZING MODIFIED NUCLEIC ACID | FUJITSU LIMITED (JP) | 2009-03-05 | — | — | US | claimed |
| CN-101356155-A | Phenoxyacetic acids as PPAR-delta activators | TRANSTECH PHARMA (US) | 2009-01-28 | — | — | CN | claimed |
| EP-1883620-A1 | ß-AMINO ACID DERIVATIVES | Pfizer Limited (GB) | 2008-02-06 | — | — | EP | claimed |
| WO-2006120544-A1 | β-AMINO ACID DERIVATIVES | PFIZER LIMITED (GB) | 2006-11-16 | — | — | WO | claimed |
| WO-2005030735-A1 | TRIAZINES DERIVATIVES AS CELL ADHESION INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2005-04-07 | — | — | WO | claimed |
| CN-1507442-A | Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors | — | 2004-06-23 | — | — | CN | claimed |
| EP-0446299-A4 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | — | 1992-05-13 | — | — | EP | claimed |
| EP-0446299-A1 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-09-18 | — | — | EP | claimed |
| WO-1990005785-A1 | METHOD FOR SITE-SPECIFICALLY INCORPORATING UNNATURAL AMINO ACIDS INTO PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1990-05-31 | — | — | WO | claimed |
| CN-109790114-B | Novel chiral ligand, metal chelate, various unnatural amino acids and synthesis method of maraviroc and key intermediate thereof | 中国科学院上海药物研究所 | 2025-03-07 | — | — | CN | disclosed |
| EP-0337348-A2 | Amides of cyclomethylen-1,2-bicarboxylic acids having therapeutical activity, processes for their preparation and pharmaceutical compositions containing them | Laboratori Guidotti S.p.A. (IT) | 1989-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062521-A1 | AMIDITE FOR SYNTHESIZING MODIFIED NUCLEIC ACID AND METHOD FOR SYNTHESIZING MODIFIED NUCLEIC ACID | NSUN2, RNMT, ADAR | CYP1A2 2576/4885CPA1 953/4885CPA3 4398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.